Company intelligence / Profile preview

Sinol Singapore

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Sinol Singapore is the official distributor of Sinol USA's all-natural, capsaicin-based nasal sprays in Singapore. Operated by Grace Cross Pte. Ltd., the company provides fast-acting, clinically proven over-the-counter (OTC) relief for migraines, chronic sinus issues, allergies, and nasal congestion. Its flagship product, Sinol-M, utilizes a unique homeopathic formula containing capsaicin, aloe vera, eucalyptus oil, and rosemary extract to relieve pain and inflammation without the side effects of rebound congestion or drowsiness. Sinol Singapore distributes these products locally through major e-groceries, retail stores, and pharmacies.

Therapeutic areas: PulmonologyOtherImmunologyNeurologyInfectious Diseases
Modalities: Small moleculeBotanical extractHerbal medicine
Industry: Pharma

Partnerships

Sinol USA

Beyond the preview

Go deeper on Sinol Singapore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinol Singapore.

Explore the full profile